Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Ethics Subcommittee (ES)

---
identifier: "/us/fr/2012-23192"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Ethics Subcommittee (ES)"
title_number: 0
title_name: "Federal Register"
section_number: "2012-23192"
section_name: "Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Ethics Subcommittee (ES)"
positive_law: false
currency: "2012-09-20"
last_updated: "2012-09-20"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-23192"
document_type: "notice"
publication_date: "2012-09-20"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "77 FR 58397"
fr_volume: 77
---


#  Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Ethics Subcommittee (ES)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee:

*Time and Date:* 8:30 a.m.-2:30 p.m., EDT, Thursday, October 11, 2012.

*Place:* CDC, Thomas R. Harkin Global Communications Center, Distance Learning Auditorium, 1600 Clifton Road, NE., Atlanta, GA 30333. This meeting is also available by teleconference. Please dial (877) 928-1204 and enter code 4305992.

*Status:* Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment period. The public comment period is tentatively scheduled for 2 p.m.-2:10 p.m.

*Purpose:* The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners.

*Matters To Be Discussed:* Agenda items will include the following topics: Ethical considerations relating to use of travel restrictions for the control of communicable diseases; addition of ethics standards to the accreditation process for public health departments; approaches for evaluating the impact of public health ethics activities; progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges; and strategies for  increasing collaboration between public health ethics and public health law.

The agenda is subject to change as priorities dictate.

*Contact Person for More Information:* For security reasons, members of the public interested in attending the meeting should contact Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC—ES, 1600 Clifton Road NE., M/S D-50, Atlanta, Georgia 30333. Telephone: (404) 639-4690. Email: *[email protected].* The deadline for notification of attendance is October 1, 2012.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: September 12, 2012.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.